Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax

The unpredictable nature of bioterrorism and the absence of real-time detection systems have highlighted the need for an efficient postexposure therapy for Bacillus anthracis infection. One approach is passive immunization through the administration of antibodies that mitigate the biological action...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Albrecht, Mark T., Li, Han, Williamson, E. Diane, LeButt, Chris S., Flick-Smith, Helen C., Quinn, Conrad P., Westra, Hans, Galloway, Darrell, Mateczun, Alfred, Goldman, Stanley, Groen, Herman, Baillie, Les W. J.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology (ASM) 2007
Θέματα:
Microbial Immunity and Vaccines
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2168292/
https://ncbi.nlm.nih.gov/pubmed/17646360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00261-07
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια